Microbot Medical to Address Misleading Article Claims in Conference Call

Microbot Medical Inc. announced it will host an analysts and investors conference call on May 18th to address and correct misleading statements and misrepresentations made in a recent unaffiliated third-party article. The company aims to ensure the investing public is fully informed about its LIBERTY Endovascular Robotic System. A Wall Street firm has already published a research report refuting the article's claims, and a vascular surgeon will also dispute assertions attributed to him during the call. The conference will also cover the recent progress of the LIBERTY System's Full Market Release.